Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Originally developed as diabetes medications, new glucagon-like peptide-1 (GLP-1) medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) suppress a patients appetite, slow gastric emptying, and help the pancreas increase its production of insulin to regulate blood sugar
Adults aged 25-34 were the most positive about tablets Adults between 25 and 34 were the most likely age group to say tablets feel more appealing than injections
(Cell Metabolism 2022)
The medication is available without insurance requirements, no membership fees, and qualifies for HSA/FSA accounts
The study tested once-weekly subcutaneous doses from 0.5 mg up to 12 mg and showed a clear dose-response signal
US$ 20.89
US$ 20.19
US$ 28.94
